About PicnicResearch

Clinical research, reinvented

Clinical research is the rate-limiting factor in drug development. It's two-thirds of the cost and two-thirds of the timeline. It's the reason too many promising therapies never reach the patients who need them.

PicnicResearch exists to change that. We design and run patient-connected clinical studies that generate stronger evidence, faster, so sponsors can answer the questions that matter and move better treatments forward.

How we work

Our approach brings together three principles most research organizations treat as separate:

01

Patient-connected study design.

We work directly with patients, not through fragmented site networks. That means real-world populations, longitudinal data that actually reflect how conditions progress, and evidence that holds up to scrutiny.

02

AI-enhanced research infrastructure.

Our process is built on more than a decade of turning unstructured care delivery touchpoints into usable clinical data. Our evidence is fit for regulated research: accurate, traceable, and designed to scale.

03

Scientific expertise.

Our scientific delivery team, including biostatisticians, epidemiologists, and clinical data experts, designs studies with the rigor sponsors and regulators expect. Better science, not just faster science.

The combination is what changes the math. Studies that enroll faster, generate richer evidence, and cost less to run.

Patient connection is our foundation

PicnicResearch is built on something most research organizations have to approximate: a direct, ongoing relationship with patients.

For more than a decade, we have structured longitudinal health data for tens of thousands of patients across dozens of conditions: not claims data, not EHR extracts, not siloed snapshots from any one single system, but comprehensive records spanning every provider, site of care, and data source a patient's history touches, made research-ready. We've run surveys, connected wearables, performed remote assessment, collected blood draws – all with the ease and convenience of being in the patient's home.

The result is a research model with structural advantages: populations that reflect how conditions actually present, data that captures the full arc of a patient's experience, and evidence built for the questions regulators and payers are increasingly asking — not just the ones that are easiest to answer.

Infrastructure built for the evidence that matters most

The studies sponsors bring to PicnicResearch tend to share a common thread: standard approaches weren't going to get them there. Chart review was too slow. Claims data was too shallow. Site-based enrollment couldn't find the population.

We work across drug development, label expansion, and post-market requirements — including long-term safety and effectiveness studies where longitudinal depth is the whole point. Our evidence is designed to hold up where it needs to: regulatory submissions, payer negotiations, or publication.

The experts behind the science

Our scientific delivery team includes biostatisticians, epidemiologists, and clinical data scientists who have spent their careers designing studies that regulators trust and sponsors can act on. They work alongside our medical and scientific leadership to ensure every study we run reflects the standards the field expects, and the rigor it increasingly requires.

Our Customer Advisory Board

Our Customer Advisory Board brings together senior research and development leaders from across the life sciences industry. They help us pressure-test our capabilities, stay calibrated to what sponsors actually need, and ensure PicnicResearch is solving the right problems as the field evolves.

Marisa Co
Former Vice President Real World Data Analytics, Innovation & Partnerships
Luisa Luciani
Head of Medical ADC Lung Cancer, AstraZeneca
Rich Polgar
Managing Advisor, Danforth Advisors
Gaelan Ritter
Head of Innovation and Digital Health Analytics, Sanofi
Antoniu (Tony) Fantana
Global Regulatory Affairs Innovation and Technology Lead, Eli Lilly and Company
Henry Cheng
Senior Director, HEOR, Neurocrine Biosciences
Krishna Cheriath
Chief Digital Officer, Thermo Fisher Scientific
Hassan Kadhim
Head of Business Engagement for Clinical Operations and Clinical Development, Vertex Pharmaceuticals
Ryan Kilpatrick
Vice President of Epidemiology, AbbVie